# ChiRhoClin, Inc – FDA Inspection, Sep 15, 2025

Source: https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/e0fb5200-f0cd-48e1-b8f8-a761682704e7
Source feed: FDA_Inspections

> FDA inspection 1282054 of ChiRhoClin, Inc, September 15, 2025. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1282054
- Company Name: ChiRhoClin, Inc
- Inspection Date: 2025-09-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Baltimore District Office
- Citation Count: 8

## Related Documents

- [FDA Inspection 1190730 - 2022-11-03](https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/ec4ff8e9-44fa-4619-9428-b49c5b7f8c4b)
- [FDA Inspection 1011966 - 2017-05-30](https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/a13098d9-f297-47e5-9353-81c2bd4b9f28)
- FDA Inspection 798256 - 2012-09-07
- [FDA Inspection 774375 - 2012-04-03](https://www.keypedia.com/records/fda_inspections/chirhoclin-inc/b01ffdf8-ca7d-479f-b2d1-1d42d0262220)
- FDA Inspection 585522 - 2009-05-26

## Related Officers

- [Company Rep](https://www.keypedia.com/people/catherine-o-lamptey/9ddfa564-70b7-4a8b-9209-9d21205ebf60)
- [Issuing Officer](https://www.keypedia.com/people/claude-noel-y-zanetsie/d2341300-2c9d-4d22-bb70-5b442d4e3b70)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)

Company: https://www.keypedia.com/companies/chirhoclin-inc/a63ad8fd-139c-40ea-bc63-d690e9b58437

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
